Literature DB >> 7451615

Extraction and quantification of daunomycin and doxorubicin in tissues.

J F Strauss, R L Kitchens, V W Patrizi, E P Frenkel.   

Abstract

The measurement of intracellular concentrations of the anti-cancer drug doxorubicin was performed by the application of a simple cell extraction technique combined with a rapid high-performance liquid chromatographic separation. Quantitation was done by fluorescence detection. The extraction procedure was non-degradative and the mean recovery of drug was 95%. A high drug extraction efficiency was confirmed with radiolabeled [3H] doxorubicin. The method is applicable to normal and neoplastic tissue.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7451615     DOI: 10.1016/s0378-4347(00)81015-4

Source DB:  PubMed          Journal:  J Chromatogr


  7 in total

1.  Quantitation of cell-associated doxorubicin by high-performance liquid chromatography after enzymatic desequestration.

Authors:  A Andersen; D J Warren; L Slørdal
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

2.  Cellular pharmacokinetics of daunorubicin: uptake by leukaemic cells in vivo and fate.

Authors:  V Trillet; M Lakhal; J Lang; E Perrin-Fayolle; Q Timour Chah; D Fière; G Faucon
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

3.  A simplified method for determination of daunorubicin, adriamycin, and their chief fluorescent metabolites in human plasma by high-pressure liquid chromatography.

Authors:  W Bolanowska; T Gessner; H Preisler
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

Review 4.  Anthracycline antitumour agents. A review of physicochemical, analytical and stability properties.

Authors:  J Bouma; J H Beijnen; A Bult; W J Underberg
Journal:  Pharm Weekbl Sci       Date:  1986-04-25

5.  Doxorubicin concentration time course in the myocardium after single administration to the dog. Possible role in the cardiac effects.

Authors:  Q Timour; P Nony; J Lang; M Lakhal; V Trillet; G Faucon
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

6.  Doxorubicin concentrations in plasma and myocardium and their respective roles in cardiotoxicity.

Authors:  Q Timour; P Nony; J Lang; M Lakhal; V Trillet; G Faucon
Journal:  Cardiovasc Drugs Ther       Date:  1988-01       Impact factor: 3.727

7.  Daunomycin-arachidonic acid complex as a potential new antitumor agent.

Authors:  T Sasaki; Y Tsukada; H F Deutsch; H Hirai
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.